Animal studies show experimental injection reverses osteoarthritis

Researchers at the University of Colorado Boulder have demonstrated that a single injected drug-delivery system can reverse osteoarthritis in animals within weeks. The team, led by chemical and biological engineer Stephanie Bryant, reported success in early animal experiments. They aim to advance to human trials after further safety testing.

A team from the University of Colorado Boulder has developed an experimental slow-release drug-delivery system that, when injected into damaged joints, prompts the body's cartilage and bone cells to repair osteoarthritis effectively in just weeks, according to ongoing animal experiments not yet peer-reviewed. Stephanie Bryant stated, 'In two years, we were able to go from a moonshot idea to developing these therapies to demonstrating that they reverse osteoarthritis in animals.' The researchers are now preparing for phase two, which will assess safety and toxicology to pave the way for human clinical trials within the next 18 months, pending results from additional animal studies. Bryant's goal is clear: 'not just to treat pain and halt progression, but to end this disease.' Currently, osteoarthritis—a condition affecting hundreds of millions worldwide with no cure—leaves patients managing pain or undergoing joint replacements. Evalina Burger, professor and chair of the Department of Orthopedics at UC Anschutz, noted, 'At the moment, the options for many patients are either a massive, expensive surgery or nothing. There's not a lot in between.' The team is also working on an injectable implant to recruit cells for cartilage repair, offering options for different stages of the disease. Funding comes from the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program under ARPA-H, part of the US Department of Health and Human Services. ARPA-H Director Alicia Jackson said, 'Through ARPA-H, we are driving toward a future where people don't have to wake up in pain, give up activities they love, or face major surgeries and repeat joint replacements – so they can stay active, independent, and healthy for longer.'

ተያያዥ ጽሁፎች

Scientific illustration depicting parathyroid hormone strengthening mouse vertebral endplates to repel pain nerves, reducing chronic low back pain in spinal degeneration models.
በ AI የተሰራ ምስል

Study links parathyroid hormone to reduced chronic low back pain in mice by limiting abnormal nerve growth

በAI የተዘገበ በ AI የተሰራ ምስል እውነት ተፈትሸ

A study published in the journal *Bone Research* reports that parathyroid hormone (PTH) reduced pain-related behaviors in mouse models of spinal degeneration, apparently by strengthening vertebral endplates and triggering bone-cell signals that repel pain-sensing nerve fibers. The work was led by Dr. Janet L. Crane of Johns Hopkins University School of Medicine.

Millions worldwide suffer from osteoarthritis, yet many miss out on the most effective treatment: exercise. Experts highlight that movement nourishes joints and reduces pain more than surgery or medications in many cases. Studies show fewer than half of diagnosed patients receive referrals for physical activity programs.

በAI የተዘገበ

Researchers at University College London have discovered how the body naturally shuts down inflammation using fat-derived molecules called epoxy-oxylipins. These molecules prevent the buildup of immune cells linked to chronic diseases like arthritis and heart disease. A study involving a drug that boosts these molecules showed faster pain relief and reduced harmful immune activity.

A nasal spray delivering a broad-spectrum antibody has demonstrated potential to prevent infections from any flu strain in animal and preliminary human studies. Developed initially by Johnson & Johnson and now advanced by Leyden Labs, the spray could offer rapid protection during pandemics. Experts see it as a valuable tool for high-risk groups, though further testing is needed.

በAI የተዘገበ እውነት ተፈትሸ

Northwestern University researchers say they developed an advanced lab-grown human spinal cord organoid model that reproduces key features of traumatic injury—such as inflammation and glial scarring—and that an experimental “dancing molecules” therapy reduced scar-like tissue and promoted nerve-fiber growth in the model.

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ